Purchases and Sales Made in Q3 2023 in Aslan Pharmaceuticals LTD (ASLN)
This table provides information about the institutional ownership of Aslan Pharmaceuticals LTD (ASLN) during Q3 2023. The information is specifically focused on institutions that hold shares of ASLAN Pharmaceuticals Ltd.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Oct 25, 2023
Q3 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Oct 30, 2023
Q3 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Nov 08, 2023
Q3 2023
|
Vivo Capital, LLC
Palo Alto, CA |
SELL
|
- |
-2.27M- 80.0% |
$4.2M - $8.66M
|
568K
$341K
|